Exploring the role and function of trial steering committees: Results of an expert panel meeting

Trials

Volumn 16, Issue 1, 2015, Pages

  Harman, Nicola L ^a   Conroy, Elizabeth J ^a   Lewis, Steff C ^b   Murray, Gordon ^b   Norrie, John ^c   Sydes, Matt R ^d,e   Lane, J Athene ^f   Altman, Douglas G ^g   Baigent, Colin ^g   Bliss, Judith M ^h   Campbell, Marion K ⁱ   Elbourne, Diana ^j   Evans, Stephen ^j   Sandercock, Peter ^b   Gamble, Carrol ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Centre for Healthcare Randomised Trials (CHaRT)   (United Kingdom)

^d MRC CLINICAL TRIALS UNIT   (United Kingdom)

^e All Ireland Hub for Trials Methodology Research   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

Clinical trial; Data monitoring committee; Executive committee; Oversight committee; Randomised controlled trial; Terms of reference; Trial steering committee; Trials

Indexed keywords

CLINICAL ARTICLE; DNA TRANSCRIPTION; GENETIC TRANSCRIPTION; HUMAN; LIFESPAN; MEDICAL RESEARCH; PROFESSIONAL STANDARD; RESPONSIBILITY; UNCERTAINTY; ADVISORY COMMITTEE; CLINICAL TRIAL (TOPIC); CONFLICT OF INTEREST; CONSENSUS; CONSENSUS DEVELOPMENT; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PERSONNEL; QUESTIONNAIRE; STANDARDS; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

ADVISORY COMMITTEES; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS DATA MONITORING COMMITTEES; COMMITTEE MEMBERSHIP; CONFLICT OF INTEREST; CONSENSUS; DATA INTERPRETATION, STATISTICAL; HUMANS; PROFESSIONAL ROLE; RESEARCH DESIGN; RESEARCH PERSONNEL; RESEARCH SUPPORT AS TOPIC; SURVEYS AND QUESTIONNAIRES;

EID: 84953379166     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-1125-z     Document Type: Article

References (24)

1. Medical Research Council. Guidelines for good clinical practice in clinical trials 1998. http://www.mrc.ac.uk/documents/pdf/good-clinical-practice-in-clinical-trials/. Accessed 28-12-2015.
2. Grant A, Altman D, Babiker A, Campbell M, Clemens F. Issues in data monitoring and interim analysis of trials. Health Technol Assess. 2005;9:238. doi: 10.3310/hta9070.
3. DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005;365:711-22. doi: 10.1016/S0140-6736(05)17965-3.
4. Conroy EJ, Harman NL, Lane JA, Lewis SC, Murray G, Norrie J et al. Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences. Clinical Trials. 2015. doi: 10.1177/1740774515589959.
5. Sydes MR, Spiegelhalter DJ, Altman DG, Babiker AB, Parmar MK, Group D. Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials. Clin Trials. 2004;1:60-79. doi: 10.1191/1740774504cn004rr.
6. Tudur Smith C HC, Sydes M, Woolfall K, Clarke M, Murray G, Williamson P. Good Practice Principles for Sharing Individual Participant Data from Publicly Funded Clinical Trials. 2015. http://www.methodologyhubs.mrc.ac.uk/files/7114/3682/3831/Datasharingguidance2015.pdf. Accessed 28-12-2015.
7. National Institute for Health Research Health Technology Assessment Programme. Research Governance Guidelines. 2012. http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0010/77167/TSC_and_DMEC_Guidelines.pdf. Accessed 28-12-2015.
8. Daykin A, Heawood A, Lane A, Macefield R, Gamble C, McCann S, et al. An ethnographic study of group decision making to understand and improve how trial steering committees contribute to trial conduct. Trials. 2013;14 Suppl 1:O79.
9. The Medicines for Human Use (Clinical Trials) Regulations 2004. http://www.legislation.gov.uk/uksi/2004/1031/regulation/3/made. Accessed 28-12-2015.
10. Department of Health. Research governance framework for health and social care: second edition. 2005. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/139565/dh_4122427.pdf. Accessed 28-12-2015.
11. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6 (R1) 1996. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf. Accessed 28-12-2015.
12. Evans S. When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial? PLoS Clin Trials. 2007;2:e18. doi: 10.1371/journal.pctr.0020018.
13. Wittes J. On changing a long-term clinical trial midstream. Stat Med. 2002;21:2789-95. doi: 10.1002/sim.1282.
14. Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respir Med. 2014;2:728-37. doi: 10.1016/S2213-2600(14)70157-2.
15. Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, et al. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 2014;15:1109-18. doi: 10.1016/S1470-2045(14)70361-4.
16. Campbell JL, Fletcher E, Britten N, Green C, Holt TA, Lattimer V et al. Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis. Lancet.2014;384:1859-68. doi: 10.1016/S0140-6736(14)61058-8.
17. Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D et al. Long-term clinical and cost-effectiveness of psychological intervention for family carers of people with dementia: a single-blind, randomised, controlled trial. Lancet Psychiatry. 2014;1:539-48. doi: 10.1016/S2215-0366(14)00073-X.
18. Pd Med Collaborative Group. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet. 2014;384:1196-205. doi: 10.1016/S0140-6736(14)60683-8.
19. CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial. Lancet Neurol. 2014;13:1186-92. doi: 10.1016/S1474-4422(14)70258-3.
20. McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S, Davies RJ et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. Lancet Respir Med. 2014;2:804-12. doi: 10.1016/S2213-2600(14)70172-9.
21. Establishing a database of statistical expertise to support clinical trial oversight committees and develop capacity 2013. http://www.methodologyhubs.mrc.ac.uk/research/network-projects#block2013-06 Accessed 28-12-2015.
22. Conroy E, Lewis S, Lane A, Sydes M, Norrie J, Murray G, et al. Trial steering committees for randomised controlled trials: updating and redeveloping guidance and terms of reference informed by current practice and experience. Trials. 2013;14 Suppl 1:128.
23. Buck D, Gamble C, Dudley L, Preston J, Hanley B, Williamson PR, et al. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials. BMJ Open. 2014;4:e006400. doi: 10.1136/bmjopen-2014-006400.
24. Dudley L, Gamble C, Preston J, Buck D, Hanley B, Williamson P, et al. What Difference Does Patient and Public Involvement Make and What Are Its Pathways to Impact? Qualitative Study of Patients and Researchers from a Cohort of Randomised Clinical Trials. PLoS One. 2015;10:e0128817. doi: 10.1371/journal.pone.0128817.